The heterogeneity of metabolite effects as identified in this study might, in part, explain inconsistencies (e.g., ref. 67 vs. ref. 68) in associations of metabolites and AD reported in other studies (e.g., if sex and APOE genotype are distributed differently and sample sizes are small). Here, APOE is linked to Alzheimer disease.